Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Toni Ibrahim

Showing results (121-130 of 223) with videos related to

Pageof 23
Sort By:
Bone|June 24, 2014
CSF-1 blockade impairs breast cancer osteoclastogenic potential in co-culture systemsChiara Liverani, Laura Mercatali, Chiara Spadazzi, et al.
Nature Cell Biology|October 23, 2012
Elf5 inhibits the epithelial-mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2Rumela Chakrabarti, Julie Hwang, Mario Andres Blanco, et al.
Heart (British Cardiac Society)|January 26, 2013
Trastuzumab-induced cardiotoxicity in early breast cancer patients: a retrospective study of possible risk and protective factorsAlberto Farolfi, Elisabetta Melegari, Michele Aquilina, et al.
Molecular Oncology|June 10, 2021
Lineage-specific mechanisms and drivers of breast cancer chemoresistance revealed by 3D biomimetic cultureChiara Liverani, Alessandro De Vita, Chiara Spadazzi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 1, 2024
Treatment of bone metastases from solid tumors with bone-modifying agents: a web survey of Italian oncologists investigating patterns of practice drug prescription and prevention of side effectsVittorio Fusco, Massimo Di Maio, Anna Amela Valsecchi, et al.
BMJ Open|July 22, 2020
Randomised phase II trial of CAPTEM or FOLFIRI as SEcond-line therapy in NEuroendocrine CArcinomas and exploratory analysis of predictive role of PET/CT imaging and biological markers (SENECA trial): a study protocolAlberto Bongiovanni, Chiara Liverani, Sara Pusceddu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 17, 2019
Ten-year experience of the multidisciplinary Osteoncology CenterAlberto Bongiovanni, Federica Recine, Valentina Fausti, et al.
Therapeutic Advances in Medical Oncology|July 5, 2022
Myxofibrosarcoma landscape: diagnostic pitfalls, clinical management and future perspectivesSilvia Vanni, Alessandro De Vita, Lorena Gurrieri, et al.
Frontiers in Immunology|December 3, 2021
Immune Checkpoint Inhibitors With or Without Bone-Targeted Therapy in NSCLC Patients With Bone Metastases and Prognostic Significance of Neutrophil-to-Lymphocyte RatioAlberto Bongiovanni, Flavia Foca, Jessica Menis, et al.
Frontiers in Oncology|June 19, 2026
Molecular tumor board availability and organization in sarcoma referral centers in Italy: are we on the right track?Concetta Elisa Onesti, Beatrice Casini, Annarosaria De Chiara, et al.
Pageof 23

Showing results (121-130 of 223) with videos related to

Sort By:
Pageof 23
Bone|June 24, 2014
CSF-1 blockade impairs breast cancer osteoclastogenic potential in co-culture systemsChiara Liverani, Laura Mercatali, Chiara Spadazzi, et al.
Nature Cell Biology|October 23, 2012
Elf5 inhibits the epithelial-mesenchymal transition in mammary gland development and breast cancer metastasis by transcriptionally repressing Snail2Rumela Chakrabarti, Julie Hwang, Mario Andres Blanco, et al.
Heart (British Cardiac Society)|January 26, 2013
Trastuzumab-induced cardiotoxicity in early breast cancer patients: a retrospective study of possible risk and protective factorsAlberto Farolfi, Elisabetta Melegari, Michele Aquilina, et al.
Molecular Oncology|June 10, 2021
Lineage-specific mechanisms and drivers of breast cancer chemoresistance revealed by 3D biomimetic cultureChiara Liverani, Alessandro De Vita, Chiara Spadazzi, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|March 1, 2024
Treatment of bone metastases from solid tumors with bone-modifying agents: a web survey of Italian oncologists investigating patterns of practice drug prescription and prevention of side effectsVittorio Fusco, Massimo Di Maio, Anna Amela Valsecchi, et al.
BMJ Open|July 22, 2020
Randomised phase II trial of CAPTEM or FOLFIRI as SEcond-line therapy in NEuroendocrine CArcinomas and exploratory analysis of predictive role of PET/CT imaging and biological markers (SENECA trial): a study protocolAlberto Bongiovanni, Chiara Liverani, Sara Pusceddu, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|January 17, 2019
Ten-year experience of the multidisciplinary Osteoncology CenterAlberto Bongiovanni, Federica Recine, Valentina Fausti, et al.
Therapeutic Advances in Medical Oncology|July 5, 2022
Myxofibrosarcoma landscape: diagnostic pitfalls, clinical management and future perspectivesSilvia Vanni, Alessandro De Vita, Lorena Gurrieri, et al.
Frontiers in Immunology|December 3, 2021
Immune Checkpoint Inhibitors With or Without Bone-Targeted Therapy in NSCLC Patients With Bone Metastases and Prognostic Significance of Neutrophil-to-Lymphocyte RatioAlberto Bongiovanni, Flavia Foca, Jessica Menis, et al.
Frontiers in Oncology|June 19, 2026
Molecular tumor board availability and organization in sarcoma referral centers in Italy: are we on the right track?Concetta Elisa Onesti, Beatrice Casini, Annarosaria De Chiara, et al.
Pageof 23